Conference Program Day 2

Prof. Abdullah Molokhia

Professor, Pharmaceutics, | Egypt

Prof. Molokhia obtained his PhD from the University of Michigan, USA 1973. He held academic positions at Universities of Houston, Riyadh and Alexandria and is a current member of the Egyptian National Pharmacology Committee. He advised more than 52 PhD and MS candidates and co-authored more than 158 original manuscripts and presentations to national and international conferences. Between 1996-2004, he was the chairman of the Egyptian National Organization for Drug Control and Research at the Ministry of Health. From 2004 until 2013, he chaired the European Egyptian Pharmaceutical Industries Company, a division of Pharco Pharmaceuticals, Alexandria, Egypt. Between 2007-2013, he chaired the Pharmaceutical Sector of the Pharmaceuticals and Cosmetic Chamber at the Egyptian Industry Union. Prof. Molokhia chaired several conferences organized among NODCAR, the MOH and the WHO. As consultant to the WHO, he presented training and consultations to nine countries in the EMRO region. Prof. Molokhia co-chaired 5 Egyptian-USP Symposia on “Science and Standards”. He acts as observer representing the Egyptian Chamber of Pharmaceuticals with the USP Convention.

Prof. Albert Wertheimer

Nova Southeastern University, Florida, | USA

Dr. Albert Wertheimer has been active in sociobehavioral and administrative pharmacy research and education for more than 30 years. He earned a pharmacy degree at the University of Buffalo, an M.B.A. from the State University of New York at Buffalo and his Ph.D. at Purdue University. In addition, he completed a post-doctoral research fellowship in the department of social medicine at St. Thomas” Hospital Medical School of the University of London. He has directed nearly 100 Ph.D. students and more than that number of master’s students. He is the author or editor of 40 books, numerous book chapters and about 430 journal articles. He has lectured or consulted in about 75 countries, and he holds visiting professor appointments at universities in Mexico, Taiwan, Turkey, Slovenia and China. He performed pioneering work in the area of social and behavioral sciences in pharmacy and in more recent years has conducted research in pharmaco-economics, outcomes research, and health policy analysis. Prior to his appointment at NSU, he has been a professor at Temple University, dean of the Philadelphia College of Pharmacy, a researcher at Merck and Company, a vice president of First Health, Inc., a Pharmacy Benefit Manager and a professor and director of graduate studies at the University of Minnesota. Dr. Wertheimer has received many awards and recognitions including fellowships from the American Association of Pharmaceutical Scientists and the International Pharmacy Federation (FIP). He is Scheele Laureate and an honorary member of several professional societies. He has been a study section member/grant reviewer for the US NIH and for AHRQ. Current research interests include pharmaceutical counterfeiting, off label prescribing and cost:benefit studies.

Prof. Qutayba Hamid

Vice Chancellor for Medical & Health Science Colleges and Dean, College of Medicine, University of Sharjah, | United Arab Emirates

Personal Details/Academic Background Professor Qutayba Hamid is a distinguished scientist in Respiratory Medicine and a researcher in Asthma; he is currently the Vice Chancellor for Medical and Health Sciences and the Dean of the College of Medicine in the University of Sharjah, United Arab Emirates. Prof. Qutayba was born in Mosul, Iraq. He graduated from the College of Medicine, Mosul University and was trained at the University Hospital in Mosul before travelling to the UK to continue his studies at the Imperial College of London. He served as a lecturer at the National Heart and Lung Institute in London and as a researcher on asthma and allergies. Research and Achievements: Professor Qutayba moved to McGill University in Canada in 1993 where he was appointed as an associate professor and then as a professor of Respiratory diseases. He joined the MeakinsChristie institute as a researcher and then as a Director till 2016. He held the prestigious James McGill Chair and clinical Strauss Chair in Respiratory Medicine. Recently, he was elected as a fellow of the prestigious Royal Society to become one of the few in his field to join the society. He is also a member of the Royal College of Internal Medicine in the United Kingdom, a member of the Royal College of Internal Medicine in Canada, and a visiting professor at several international universities. Professor Qutayba’s research interest is mainly focused on asthma. He has published over 500 research papers in prominent international journals, making him one of the top researchers ever to publish on Asthma, and has led to changing the concept of asthma and to the discovery of new drugs that are currently used to treat it. He has additionally contributed to the publishing of textbook chapters on Respiratory diseases. His lab in Montreal was an important training ground for respiratory professionals, graduate students and postdoctoral fellows from all over the world. Being an expert in the field of allergy, asthma and lung diseases, Professor Hamid has been elected to be a member of numerous scientific advisory boards associations and societies.

Prof. Linda S. Tyler,

Pharm.D., FASHP, Professor (Clinical) of Pharmacotherapy, University of Utah College of Pharmacy, | USA

LINDA S. TYLER, Pharm.D., FASHP, is Professor (Clinical) of Pharmacotherapy, University of Utah College of Pharmacy. Previously, she was the Chief Pharmacy Officer for University of Utah Health; and Associate Dean for Pharmacy Practice, University of Utah College of Pharmacy. Tyler received her B.S. in Pharmacy and Pharm.D. degrees from the University of Utah. She completed a pharmacy practice residency at University of Nebraska Medical Center. She was a faculty member and critical care practitioner at the University of Wisconsin and a poison control center specialist at Nationwide Children's Hospital. She returned to the University of Utah as Director of Drug Information Services. She served in that role for many years before becoming the senior pharmacy leader for University of Utah Health. Tyler is a tireless advocate for progressive and innovative pharmacy services in health systems. She was the residency program director for the HSPAL program and prior to that for the Drug Information residency. Tyler has served ASHP in many capacities, most recently as President. She previously served as a Board Member, Chair of the Council on Pharmacy Management and as Director-at-Large of the Section of Clinical Specialists and Scientists Executive Committee. She has also served on the Councils on Organizational Affairs, Therapeutics, Education and Workforce Development, and Pharmacy Practice; the Committee on Nominations; Section of Ambulatory Care Practitioners; New Practitioner and Student Forums; and a delegate to the House of Delegates for many years. She is a Past President of USHP. Dr. Tyler was the 2015 recipient of the John Webb Award, given by ASHP in recognition of outstanding leadership.

Prof. Dario Cattaneo

President of IATDMCT, Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Milan, . | Italy

Dr. Dario Cattaneo has Pharmacy degree and post-degree specialization in Pharmacology both awarded by the University of Milan, Italy. PhD degree in Biomedical Sciences awarded by the Open University of London, UK. Later on, he obtained a Master of Transplant Medicine, University of Milan; Master of Clinical Research, University of Milan, Post-degree specialization in Nephrology, University of Ferrara; AssistantProfessor of pharmacology for the degree in Medicine, University of Milan. Dr. Dario Cattaneo was theHead of the Unit of Pharmacology and Pharmacogenetics, Mario Negri Institute for Pharmacological Research, Bergamo, Italy. Since 2008 he is in charge of the Laboratory of Pharmacokinetics of the Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Milano, Italy. From October 2019, President-elect, International Association of Therapeutic Drug Monitoring and Clinical Toxicology. His areas of interest are Pharmacokinetics, pharmacodynamics, pharmacogenetics and therapeutic drug monitoring of immunosuppressants, antiviral, antifungal agents, antibiotics, antipsychotics and hypolipidemic drugs. Development of chromatographic methods for the quantification of drugs in different biological matrices. Study of potential drug-drug interactions in real life settings. Dr. Cattaneo is the author of nearly 200 scientific articles published in peer-review journals (H-index 35), seven book chapters, and over 100 abstracts presented in different international congresses. Invited speaker in nearly 300 meetings organized by national and international societies.

Prof. Yola Moride

Center for Pharmacoepidemiology & Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, . | USA

ola Moride, a pharmacoepidemiologist, joined PETS on a part-time basis in 2017 as a Research Professor. She received her Ph.D. in Pharmacoepidemiology from McGill University (1994) and post-doctoral training from University of Bordeaux (1996). She has pursued an academic career at Université de Montréal since 1996. She is Past-President of the International Society for Pharmacoepidemiology (ISPE) and past-Vice-President of the International Society of Pharmacovigilance (ISoP). She serves on the Steering Group of the European Network of Centers in Pharmacoepidemiology and Pharmacovigilance (ENCePP) at the European Medicines Agency. She has conducted several observational studies in the area of neurologic and psychiatric pharmacoepidemiology as well as therapeutic risk management. Studies include the effect of benzodiazepines on dementia and antidepressants in youth. Recently, she has conducted studies on the effectiveness of risk minimization interventions on opioid usage and opioid related harms as well as on the predictors of chronic opioid use. She is the founder and owner of YolaRX Consultants.

Prof. Emad Elazazy

Vice President and Secretary General of Egyptian Healthcare Society (EHS), | Egypt

He is a professor of governance and pharmaceutical practices at Cambridge regional U.K. and thesis advisor professor at diverse academic institutions. He had BSc. of pharm Sciences, Master of Business Administration; A.U.C., Doctor of pharmacy; Saskatchewan, Diploma in International-Economics; Cambridge, and PhD in Industrial Management, Aston University. Over the last fifteen years, he has been focusing on governance domains of practices for public, private and not-for-profit organisations, and extensively providing academic, educational and technical cutting-edge advisory consultations to a wide range of healthcare industries and academic circles on governance and health-economics. Dr Emad is the president of Value Institution for postgraduate education, a scientific board member at the National Training Institute (MOH) and a member of Governance and Social Accountability Task Force of MOH of Egypt. He also is a founding member, vice president and secretary general of Egyptian Healthcare Society, and a development committee member at the National Organization of Drug Control and Research (NODCAR). He worked for more than nine years as part-time consultant at WHOEMRO and Chairman of I.A.C. Middle East a Health Maintenance Organization. Dr Emad has been involved in and contributed to many international and regional researches on health systems, academic governance, health-economics, and governance structures and functions. As a governance adviser, he has conducted, directed and supported different governance processes at various local, regional and international assisted senior-level executives towards institutional governance enhancing operations and integration in academic governance, board governance, health and healthcare governance and health systems performance, reforms and restructuring contexts. Also, as international speaker and panellist Dr Emad delivered numerous speeches and published in different international journals on healthcare and governance related conferences and workshops. Also, he authored a number of books, articles, reports, toolkits, programs and curricula addressing post-graduate education and various aspects of academic, healthcare and governance foundations.

Prof. Derek Stewart,

President European Society of Clinical Pharmacy , Professor Clinical Pharmacy & Practice, College of Pharmacy, Qatar University, Qatar" | Qatar

Professor Derek Stewart represents the European Society of Clinical Pharmacy. He is the current President of the Society and the Editor-in-Chief of the International Journal of Clinical Pharmacy. Originally from Scotland, he joined the College of Pharmacy at Qatar University in 2019 as Professor of Clinical Pharmacy and Practice. He is an internationally renowned educator and researcher, having published more than 200 peer reviewed papers, supervised over 25 PhD students to completion and attracted significant research income. He has been collaborating with several institutions in the Middle East for some time and has presented at DUPHAT on several occasions. His research focuses on: the development, implementation and evaluation of models of pharmacy practice, notably pharmacist prescribing; medicines use, effectiveness and safety; and educational innovation. The European Society of Clinical Pharmacy (ESCP) is an international association founded in 1979 by clinical practitioners, researchers and educators from several European countries. The overall mission of the society is to promote, support, implement and advance education, practice and research in clinical pharmacy in order to optimize outcomes for patients. Specifically, the society promotes the value and impact of clinical pharmacy services among health care professionals, scientific societies, health authorities and the public; and raises awareness of clinical pharmacy practice and its activities. Individual members include clinical pharmacists, hospital pharmacists, community pharmacists, researchers and educators from over 50 countries. Pharmacists, pharmacy technicians, pharmacy students and other healthcare professionals from any country working in the community, hospital, academic setting, industry or any other healthcare setting are eligible to become members of ESCP. There are two key annual events, a major symposium in October and a workshop earlier in the year. There are also a number of practice, research and education webinars and other key clinical pharmacy related products. https://escpweb.org/ "

Dr. Saba Alheialy

Assistant Professor – Immunology, College of Medicine, MBRU, Dubai, | United Arab Emirates

Saba Al Heialy obtained her PhD degree in 2013 at McGill University, Montreal, Canada. She trained at the Meakins-Christie laboratory, a leading research center in respiratory medicine under the supervision of Dr. James G. Martin. She was awarded many scholarships throughout her PhD including the James Hogg Award in 2012 for her work on nanotubes in T cells. Currently, her research revolves around the role of the immune system in various respiratory diseases with an emphasis on the association between asthma and obesity. Moreover, she has a particular interest in the role of obesity in the COVID-19 pandemic. She is funded by the Al Jalila Research Foundation for her work on the association between asthma and lung cancer.

Prof. Jill Lavigne

Professor of Pharmacy Practice and Administration at the Wegmans School of Pharmacy, St John Fisher College, | USA

Professor of Pharmacy Practice and Administration at the Wegmans School of Pharmacy, St John Fisher College,

Prof. Barry Bleidt

Professor, Socio behavioral and Administrative Sciences, College of Pharmacy | USA

Dr. Bleidt is a Professor of Sociobehavioral and Administrative Pharmacy at Nova Southeastern University. He received his BS Pharmacy from the University of Kentucky, PhD in Pharmacy Healthcare Administration from the University of Florida, and his PharmD from Xavier University of Louisiana. Barry has forty years of professional experience in preventing drug use problems and substance misuse. Dr. Bleidt served fourteen years as Chair of the Program Committee for the Alcohol, Tobacco, and Other Drugs Section of the American Public Health Association and five years for the Pharmacy Section, twenty-three years as the parliamentarian of the American Association of Colleges of Pharmacy, and twenty-one years as the Director of Continuing Pharmacy Education for the National Pharmaceutical Association. He has served as a Delegate to the United States Pharmacopoeia Convention since 1985. Dr. Bleidt has delivered over 400 presentations and published nearly fifty works. Some of his publications include the books: Clinical Research in Pharmaceutical Development, Multicultural Pharmaceutical Education, and A Guide to the Top 200 Drugs. Dr. Bleidt was inducted as a Fellow into the APhA Academy of Pharmaceutical Research and Science in 2015. He received the 2013 Chauncey I Cooper Award (the highest honor bestowed by NPhA), 2007 Award for Innovative and Exemplary Contributions to the NPhA Foundation, the Ilene B. Stiff Local Association President’s Award as the leader of the Virginia Pharmacists Association Local Association of the Year (2001), the James M. Tyson Award (2nd Highest Honor from NPhA (2001);and the American Public Health Association Leadership Award from the Alcohol, Tobacco, and Other Drugs Section (2000). He currently resides in Ft. Lauderdale, Florida.

Prof. Stefan Muhlebach

University of Basel, Hospital Pharmacist FPH, Dept of Pharmaceutical Sciences, Div Clinical Pharmacy & Epidemiologie / Hospsital Pharmacia, | Switzerland

Education, University Teaching & Research, Memberships and Distinctions Stefan Mühlebach is a pharmacist and pharmacologist by training, working 1970-2005 as a (parttime) researcher at the Institute of Pharmacology in Bern on a project granted by the Swiss National Foundation. After his PhD thesis in 1979, he did his habilitation (university teacher) in 1993 at the Medical Faculty of the University of Bern and in 2000 in Basel where he was appointed Professor for Pharmacology and Hospital Pharmacy in 2004. He works as an external member at the Institute of Clinical Pharmacy & Epidemiology • Hospital Pharmacy at Basel. He directed so far 11 PhD, many Ms theses and published about 200 reviewed scientific papers, book chapters and guidelines with about 4500 citations and an i10 index of 53 (https://scholar.google.com/citations?user=rgN3-rwAAAAJ&hl=de ). His scientific interests are pharmacology, hospital pharmacy, clinical nutrition, nanomedicines, and regulatory sciences. He is a Faculty Member of the European Association of Parenteral and Enteral nutrition (ESPEN) contributing to basic learning books, educational courses and co-authoring national and international guidelines on clinical nutrition. He became a honorary member of the Swiss Association of Hospital Pharmacists in 2012, served as Board Member and journal editor of the European Association of Hospital Pharmacists (EAHP), for many years. He is a Fellow of the Swiss Academia of Pharmaceutical Sciences. In 2019 he got a Dr.h.c. from the Pharmacy Faculty of the Semmelweis University in Budapest. Professional activities Stefan Mühlebach worked for 25 years as chief hospital pharmacist in Switzerland, initiated the postgraduate specialization in hospital pharmacy in the 90ties and supervised the first hospital pharmacy fellows in Switzerland. Stefan Mühlebach worked from 2005-2008 with the National Agency for Therapeutic Products (Swissmedic) as Head of the Pharmacopoeia and of the Swiss Delegation at the EDQM in Strasbourg (Pharmacopoeia Europea). As an industrial pharmacist he joined Vifor Pharma Ltd and worked from 2008-2019, first as a Chief Scientific Officer in the Swiss subsidiary, afterwards as a Regulatory Science Lead for NonBiological Complex Drugs (NBCDs) / nanomedicines at the international headquarter focusing on their regulatory challenges. He chaired the NBCD Working Group at Lygature in the Netherland from its beginning in 2009 to 2019. Since 2010 he is in a part-time job at the Federal Office of National Economic Supply (FONES) as Head of Therapeutic Products to manage drug shortages in Switzerland. Actually, he is also in charge in a part-time job as head of the working group on logistics for the covid-19 vaccines in Switzerland at the Federal Office of Public Health.

Prof. John Papstergiou

Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada. | Canada

John Papastergiou graduated from the Leslie Dan Faculty of Pharmacy, University of Toronto in 2002. After graduation he was employed as a staff pharmacist at Sunnybrook Health Sciences Center. In 2005, John joined Shoppers Drug Mart and acquired his first store at Pape and Danforth. He now owns and operates four locations in downtown Toronto. In 2014, John received an appointment as an adjunct assistant professor at the School of Pharmacy, University of Waterloo. In 2016, he was cross appointed at the Leslie Dan Faculty of Pharmacy, University of Toronto. In addition to managing a large business, John employs his unique background in clinical research to explore an expanded role for the community pharmacist. John strongly believes that the accessibility of the community pharmacist places them in a unique position to actively screen and monitor patients for various chronic diseases. Most recently, he implemented one of the first frontline community pharmacist-directed pharmacogenomics clinics in Canada. His work in this area won first prize at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Buenos Aires, Argentina. John can be heard regularly on the Libby Fights Back Show on AM740 Zoomer Radio and on his top-rated podcast The Pharmacists Are In. In 2012, John was named the Shoppers Drug Mart Associate of the Year. In 2014, he received the OPA Mentorship Award and was named CPhA Canadian Pharmacist of the Year. In 2016, he was the recipient of the OPA Voice of the Profession Award and was awarded the Pharmacy Practice Commitment to Care Award for Overall Patient Care. In 2019, John was named by the International Forum on Advancement in Healthcare as one of the top 100 healthcare leaders globally. He was also presented with the OPA Award for Excellence in Research and Academia

Dr. Thuraya Nasser Bumozah

Clinical Pharmacist, Department of Pharmacy, MCH Hospital, Alhasa, | Saudi Arabia

Thuraya bumozah is a clinical pharmacist at the Maternity and children hospital (MCH), Alhasa-KSA. Dr.Thuraya earned her Bachelor’s degree in Pharmaceutical Sciences with honors from King Saud University in 2004 and her Master of Clinical Pharmacy from College of Pharmacy, The University of Queensland, Australia in 2010. Dr.Thuraya has more than 16 years’ experience working at Ministry Of Heath as hospital pharmacist; 10 years of them as a clinical pharmacist in the Pediatric intensive care unit. In January 2018 she was appointed as the executive director of academic and training affairs at the Maternity and children hospital Al Ahsa Thuraya participated in a large number of local scientific meetings as a speaker or organizer. She coordinated and supervised clinical pharmacy students' training programs at the hospitals where she participated in the preparation of continuing educational program, for pharmacy staff, and staff development and was appointed with several administrative pharmacy positions as a supervisor. Other areas of interest include quality improvement and medication safety.

Dr. Mohammed Al Mohaini

Asst Prof. Pharmacology, Research Coordinator, Basic Sciences Department, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Alahsa, | Saudi Arabia

Academica Electronic Portfolio (ePortfolio) is considered a student-oriented learning method. ePortfolio is created by a student of his/her course-related work such as artwork, essays, photographs, posters, and videos. In addition, ePortfolio includes other activities related to student’s experience like extracurricular activities, volunteer and employment experiences. Therefore, ePortfolio is a method of assessment that provides faculty ways for continuous collecting and assessing a student’s work, and gives the student and faculty an opportunity for evaluating the progress during a course. The importance of ePortfolio for pharmacy students as a method of learning and assessment is that it provides the student a way of reflection on his/her learning experience. In addition, faculty feedback is an essential part for an effective and productive ePortfolio in which there is a strong relationship between student’s reflection and faculty feedback. In conclusion, implementing ePortfolio will improve the education process in a pharmacy-based setting.

Dr. Faisal Alqarni

Cardiology Clinical Pharmacist, Security Forces Hospital Program, Riyadh, | Saudi Arabia

Faisal Alqarni is a cardiology clinical pharmacist at Security Forces Hospital Program - Riyadh, he earned his doctor of pharmacy (PharmD) degree from King Saud University in 2015. He has done his PGY-1 clinical pharmacy at Security Forces Hospital Program – Riyadh in 2017 - 2019, and his PGY-2 cardiology at Prince Sultan Cardiac Center in 2019 - 2020. Dr. Alqarni became an American Board-Certified Pharmacotherapy Specialist (BCPS) in 2018 and an American Board-Certified Cardiology Pharmacist (BCCP) in 2020.

Dr. Faisal ALsakr

Cardiac Clinical Pharmacist, Prince Sultan Cardiac Center, | Saudi Arabia

Faisal AL-Sakr is a cardiac clinical pharmacist at Prince Sultan Cardiac Center. He received his Doctor of Pharmacy degree from King Saud University – Riyadh in Jun 2015 and completed his PGY-1 Pharmacy Practice Residency in 2019 followed by PGY-2 cardiology Clinical Pharmacy at Prince Sultan Cardiac Center. Dr. ALsakr earned his Saudi board in cardiology clinical pharmacy in December 2020

Dr. Sultan Al Raddadi

Cardiovascular Pharmacotherapy Consultant, Cardiology Cinical Pharmacist, King Abdulaziz Medical City (KAMC), | Saudi Arabia

Dr. Sultan Al Raddadi, is cardiovascular pharmacotherapy consultant, working as cardiology clinical pharmacist at King Abdulaziz medical city (KAMC). He joined KAMC in 2004 as outpatient pharmacist and get his general clinical pharmacy board in 2009. In 2014 he get his cardiovascular pharmacotherapy board and in 2021 he become board certified cardiology pharmacist. He started his clinical pharmacy carrier in ICU in 2011 for 5 months, then nephrology till 2013, and finally king Abdulaziz cardiac center for the last 8 years. He is also a member in Advance Heart failure and heart transplant team at King Abdulaziz Cardiac Center. He is an anticoagulation expert since he is practicing in the anticoagulation clinic since 2011. Dr. Sultan is interested in training and teaching since he is a joint appoint faculty at KSAU-HS and residency preceptor at SCFHS. He was awarded as best tutor in pharmacy National Guard residency program in 2019. Sultan present many lecture in both symposiums and in site. Dr. Sultan is also a member in corporate drug evaluation committee since 2015, and Saudi society of clinical pharmacy

Dr. Muhannad Alharbi

Health Economics Consultant, HEPA Solutions Company, | Saudi Arabia

Dr. Muhannad Alharbi is health economics Advisor and founder of HEPA platform for digital health economics tools with Artificial Intelligence (AI). He holds a PharmD degree from King Abdul-Aziz University. He received his master’s degree in Drug Development and Economic Product management from University of California, San Diego, US. His background professional experiences shaped from working at pharmaceutical industries and consulting firm. - Health Economics Consultant at HEPA Solutions Company - Lecturer in Saudi Health Saudi Commission for Health Specialists - Pharmacoeconomics and pricing Advisor at SFDA - A Peer Reviewer and Speaker in ISPOR European and Saudi Arabia Chapter - Cooperative Researcher at King Saudi University - Independent Consultant in Economic Data Analytics for governmental and private sector

Dr. Mohammad Alshabeeb

Clin. Pharmacist, Pharmacogenomics Consultant, Assoc. Research Scientist, Population Health Research Section, KAIMRC), Min. National Guard - Health Affairs, | Saudi Arabia

Dr. Mohammad Alshabeeb is a Pharmacogenomics Consultant currently working as an Associate Research Scientist in the Population Health Research Section at King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard – Health Affairs in Riyadh, Saudi Arabia. He graduated from King Saud University, College of pharmacy with a Bachelor’s degree in Pharmaceutical Sciences in 1994. In 1999, he earned a Master’s Degree in Clinical Pharmacy from King Saud University, College of Pharmacy. He worked for 9 years as a clinical pharmacist providing pharmacotherapy consultations to different medical teams. In 2009, he completed another Master’s Degree in Molecular and Medical Biosciences, and then obtained the PhD Degree in Pharmacogenetics in 2014 from Newcastle University, UK. Finally, a post-doctoral fellowship training program was completed in 2017 at Utrecht University in collaboration with the Cardiovascular Genetic Research Department at University Medical Center in the Netherlands. Dr. Alshabeeb has several peer reviewed publications and abstracts in various international journals.

Dr. Aymen Ali Alqurain

Acting Consultant Pharmacist, King Fahad General Hospital, Hofuf, | Saudi Arabia

Dr. Alqurain recently graduated from University of South Australia with a doctorate degree in pharmacology (therapeutics). He holds a bachelor degree in pharmacy from Curtin University and a master degree in palliative care from Flinders University. He is a registered pharmacist in Saudi Arabia and a researcher pharmacist in Australia. Dr. Alqurain worked in different clinical settings; ICU, Palliative care, Geriatric, Internal Medicine, and currently working as an acting consultant pharmacist in King Fahad Hospital in Hofuf. His research interests include quality use of medicines, medication safety, pharmacoepidemiology, pharmacokinetics and pharmacogenetics. He is also interested in optimising drug therapy for older people while addressing issues related to polypharmacy, inappropriate prescribing and deprescribing. Currently, he is a member of the following research centres, the Therapeutic Research Centre, Queensland, the Basil Hetzel Institute at the Queen Elizabeth Hospital in Adelaide, and the Health and Biomedical Innovation centre, Adelaide.

Dr. Ali Hasan Alquraini

Faculty of Clinical Pharmacy, Al Baha University, | Saudi Arabia

Dr. Ali Alquraini is a Pharmacologist specializing in neuroinflammation. He received his BS degree in Pharmacy from the University of Jordan, and his MS and PhD in Pharmacology from Massachusetts College of Pharmacy and Health Sciences (MCPHS) University. After graduation, Dr. Alquraini completed his Postdoctoral Research Fellowship at Harvard Medical School and Massachusetts General Hospital in Boston (2019-2020). His research focuses on studying the role of scavenger receptors in neurodegeneration and inflammation and determining the roles of scavenger receptors such CD36 and LOX-1 in the pathogenesis of Alzheimer's disease. After postdoctoral work, he has joined the Faculty of Clinical Pharmacy at Al Baha University, where he is currently an Assistant Professor of Pharmacology in the Department of Pharmaceutical Chemistry. Dr. Alquraini has authored or co-authored several publications in peer-reviewed journals

Dr. Isra Al Lawati

Head of the pharmaceutical care services | Oman

Isra Al Lawati earned her postgraduate degree in MSc Clinical Pharmacy Service Development at the Robert Gordon University in Aberdeen, United Kingdom in January 2017. She earned her undergraduate degree (Bachelor) in pharmacy at Oman Medical College, Muscat in February 2011. In 2011 she joined the department of pharmacy at Al Masarra Hospital and worked as an in-charge of in-patient pharmacy for 2 years. From 2017 up to July 2021, she was working as Clinical Pharmacist specialist in the psychiatric field, mainly responsible for reviewing patients admitted in the hospital by reviewing their medications and identifying related problems, attending major rounds, applying medicine reconciliation process, providing counseling sessions and applying poly-pharmacy service in the department. She has made numerous presentations to other healthcare professional at hospital level and national level focusing in Pharmaceutical care. Aside from Isra's clinical experience in the pharmaceutical care inside the pharmacy department, she was the leader of the patient safety friendly hospital program of the pharmacy theme in Al Masarra Hospital and member of Smart pharmacy program as smart pharmacist which had been applied in Oman since 2017. She was the leader of poly-pharmacy service of the hospital and had given poster presentation in the first international patient safety day in September 2019. Moreover, she was a member of the local guidelines committee, who were responsible for developing internal policies and guidelines for the hospital sector. And a member of the research committee in the Hospital who were responsible for conducting researches and studies related to the services provided in the hospital. Now she is working as section head of the pharmaceutical care services of the hospitals in the pharmaceutical care department in the Directorate General of Medical Supplies (DGMS).

Dr. Yaqoob Alhadhrami

Clinical Pharmacist | Oman

2021- Currently works as a clinical pharmacist in acute medicine in Nizwa hospital. 2017 -2021 Worked as the head of pharmaceutical services in Nizwa Hospital- Sultanate of Oman. Obtained bachelor of pharmacy from Oman Medical College, Sultanate of Oman in November 2009. Obtained Master of Science in Clinical Pharmacy. Graduated from University of Strathclyde, UK in September 2014. Pediatric clinical pharmacist covering pediatric critical care units along with medical ward. Works as a medication safety officer in Nizwa Hospital. Member of research, drug and therapeutic committee in the hospital.

Dr. Zainab Al Hashimy

Sr.Specialized Pharmacist | Oman

Zainab Al-Hashimy is Sr. Specialized Pharmacist Plastic and Reconstruction surgery Department and Hand Surgery Department. She graduated from Ajman University of Science & Technology, Faculty of Pharmacy & Health Sciences, United Arab Emirates. Then, she joined Khoula Hospital, Ministry of health, Oman in 2006. From then, she starts her journey in Pharmacy career. She was active and fast learning in pharmacy management, and she uses her positive attitude and tireless energy to encourage others to work hard and succeed. In fact, she gets here first position as 2nd in charge of OPD pharmacies from 2006 to 2009. In 2009, she become head of Inpatient Pharmacy until she went to get her higher education in clinical pharmacy specialty which she was practicing the clinical pharmacy since 2008. She gets her MScs. Pharmacotherapy and Medicines Management. University of Sunderland. Faculty of Applied Sciences. UK, 2011. Moreover, she was member of Education & Training committee of pharmacy, hospital information system committee, Plastic and Reconstruction Department Meeting and in antimicrobial stewardship committee. In addition, she was member of taskforce committee to design the intervenes Therapy compendium for all health care practitioners in Oman in 2016. During her work, she participates in many conferences as speakers. She has two published paper. In 2020, she become the chairperson of Pharmacy Research committee. She ambitions to encourage all pharmacist to be involve in research and study. At the end, she is very happy to guide and help the one who need her advice in research.

Dr. Nadiya Al Balushi

Pharmacist & Medical Store In-charge of BSPC | Oman

Is an Omani specialized pharmacist working in the Ministry of Health in Oman (Muscat) for 19 years. She received her Master of Science in Clinical pharmacy from the University of Strathclyde in 2013. She started a service in Bowsher Specialized clinic in 2014, aiming warfarin patients to increase their compliance and knowledge by which with team in PT clinic achieved best care. From 2017 to 2021, being the pharmacist and medical stores In-Charge who had a hand in care and service improvement at Bowsher Poly Clinic. On October 2020 joined team of quality assurance & patient safety directorate in ministry of health to input the medication safety and patient safety department nationally. Recently involved in medication electronic incident reporting & learning system analysis aiming improvement of reporting.

Ms. Amal Al Shaaili

Clinical Pharmacist | Oman

Amal Ahmed Salim AL-Shaaili is a clinical pharmacist in Suhar Hospital a secondary care hospital in the Sultanate of Oman. She is responsible for developing clinical and educational initiatives designed to optimize drug therapy in the patient with kidney diseases .Although she has experience in both hospital in patient pharmacy and outpatient pharmacy practices. She is active in lecturing, research and clinical pharmacist with nephrologist. In additional to that she has been involved in drug therapeutic committee as a member. Adding to her role she is acting as Medication Safety Officer. This position involves measuring and improving medication safety in collaboration with multidisciplinary teams and individual clinicians. She evaluates medication events, quality metrics, and medication safety technology usage reports guides areas of focus. In addition, she precepts pharmacy students and develops nursing and pharmacy education as well as creates, edits, and provides lectures and patient education. Amal received her B- Pharm from Dubai Pharmacy collage in the Dubai-United Arab Emirates with very good grad, followed by MSc in Clinical Pharmacy and Service development from the Robert Gordon University-Aberdeen in the United Kingdom. During her study in Dubai she attended Duphat conference; 2005 as student participant, 2006 as poster represented &2007 as participant. Likewise during master study she trained in Scotland hospital at Aberdeen Royal Infirmary Hospital. Including to that she trained in many community pharmacies there which give her broad knowledge and experience in clinical pharmacy service and other pharmaceutical care services. Amal participated in many articles such as anti-coagulant therapy in hospitalized pregnant woman with COVD- 19 :A brief review , red man syndrome : beyond the story of Mississippi mud &antibiotic induced hypoglycemia. Including to that she is first author in study of evaluating the effective of anticholinergic drugs among elderly patient using ACB calculator.

Dr. Hana Al Ghussaini

Clinical Pharmacist | Oman

Hana Salim Sulaiman Al Ghussaini is a clinical pharmacist in Al Nahdha Hospital, a tertiary hospital in the Sultanate of Oman. In addition to her role as a clinical pharmacist, Hana is a member of the blood transfusion committee, research committee and pharmacy activities committee. She was a member of the Drug and therapeutic committee and patient safety committee. Furthermore, she is participating in the IV therapy course for nurses in the hospital. Hana received her Master of Pharmacy from Robert Gordon University-Aberdeen in the United Kingdom with Merit, followed by MSc in Clinical Pharmacy and Service development with Distinction from the same university. During her study, she trained in different hospitals in Scotland like Aberdeen Royal Infirmary Hospital and Raigmore Hospital in Inverness. Besides, she trained in many community pharmacies there which give her broad knowledge and experience in clinical pharmacy service and other pharmaceutical care services like medicines use review service, medicine reconciliation, smoking cessation and many other services. That opportunities with her speciality in clinical pharmacy and service development make her a cornerstone in initiating any pharmaceutical service in the hospital. As a clinical pharmacist, Hana is very precise and cares a lot about time management and teamwork. As a multidisciplinary team member, she is a trusted resource for all doctors in the hospital as she checks all patient prescriptions clinically and suggesting the most suitable drug as per the indication of the patient’s disease. Furthermore, she answers any question from the doctors and nurses related to the doses, compounding or dilution formula. Furthermore, she counsels patients inside the ward after discharge on potential side effects and drug interaction. Hana participated in many researches. The three major researches she leads was ‘’ Analysing antibiotics prescriptions in outpatient clinics and emergency department in Al-Nahdha Hospital in Oman’’, The knowledge, attitude and practice of parents in respect of antibiotic use for common upper respiratory tract infections in paediatric patients at Al-Nahdha hospital in Oman’’ and ‘’ Are pharmacists ready to change? pharmacy students’ expectation of pharmacy career’’.